DK98088A - Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel - Google Patents

Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel

Info

Publication number
DK98088A
DK98088A DK098088A DK98088A DK98088A DK 98088 A DK98088 A DK 98088A DK 098088 A DK098088 A DK 098088A DK 98088 A DK98088 A DK 98088A DK 98088 A DK98088 A DK 98088A
Authority
DK
Denmark
Prior art keywords
active ingredient
pharmaceutical formulation
delayed release
delayed
release
Prior art date
Application number
DK098088A
Other languages
English (en)
Other versions
DK98088D0 (da
DK175620B1 (da
Inventor
Peter Lloyd Oren
Werner Max Karl Seidler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK98088D0 publication Critical patent/DK98088D0/da
Publication of DK98088A publication Critical patent/DK98088A/da
Application granted granted Critical
Publication of DK175620B1 publication Critical patent/DK175620B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK198800980A 1987-02-27 1988-02-25 Farmaceutisk matrix-formulering i tabletform med forsinket frigivelse af den aktive bestanddel DK175620B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1991587A 1987-02-27 1987-02-27
US1991587 1987-02-27

Publications (3)

Publication Number Publication Date
DK98088D0 DK98088D0 (da) 1988-02-25
DK98088A true DK98088A (da) 1988-08-28
DK175620B1 DK175620B1 (da) 2004-12-27

Family

ID=21795732

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198800980A DK175620B1 (da) 1987-02-27 1988-02-25 Farmaceutisk matrix-formulering i tabletform med forsinket frigivelse af den aktive bestanddel

Country Status (26)

Country Link
EP (1) EP0280571B1 (da)
JP (1) JPH082793B2 (da)
KR (1) KR960005140B1 (da)
CN (1) CN1023765C (da)
AR (1) AR243376A1 (da)
AT (1) ATE92309T1 (da)
AU (1) AU604849B2 (da)
CA (1) CA1316110C (da)
CY (1) CY1741A (da)
DE (2) DE3882739T2 (da)
DK (1) DK175620B1 (da)
EG (1) EG18523A (da)
ES (1) ES2044825T3 (da)
GR (1) GR930300027T1 (da)
HK (1) HK125793A (da)
HU (1) HU202747B (da)
IE (1) IE61419B1 (da)
IL (1) IL85538A (da)
LV (1) LV10184B (da)
MX (1) MX10558A (da)
NZ (1) NZ223619A (da)
PH (1) PH24358A (da)
PT (1) PT86831B (da)
RU (1) RU1831337C (da)
UA (1) UA18251A (da)
ZA (1) ZA881301B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2113221C1 (ru) * 1990-05-04 1998-06-20 Ииссум Рисерч Дивелопмент Компани оф дзе Хебрю Юниверсити оф Иеруcалим Фармацевтическая форма для введения лекарственного средства в ободочную кишку, способ введения лекарственного препарата и способ получения матриц для такой формы
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
FR2667242B1 (fr) * 1990-09-28 1994-11-25 Rhone Poulenc Sante Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri.
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
CN1137238A (zh) * 1993-10-22 1996-12-04 株式会社津村 一种持续释放药物制剂的基料，一种持续释放药物制剂，以及该药物制剂的一种生产方法
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
PT906089E (pt) 1996-05-13 2004-01-30 Novartis Consumer Health Sa Sistema de administracao bucal
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
ATE232728T1 (de) * 1998-03-03 2003-03-15 Dae Woong Pharma Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
ES2306646T3 (es) * 1999-02-09 2008-11-16 Pfizer Products Inc. Composiciones de farmacos basicos con biodisponibilidad incrementada.
KR100647901B1 (ko) * 1999-07-09 2006-11-17 보령제약 주식회사 세파클러-함유 서방성 약제조성물 및 그의 제조방법
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
JP2003527168A (ja) 1999-12-28 2003-09-16 キンバリー クラーク ワールドワイド インコーポレイテッド 硬い表面に用いる放出制御抗菌ワイプ
JP2003530489A (ja) 1999-12-28 2003-10-14 キンバリー クラーク ワールドワイド インコーポレイテッド 放出制御抗菌剤を含むワイプ
US6794318B2 (en) 1999-12-28 2004-09-21 Kimberly-Clark Worldwide, Inc. Use-dependent indicator system for absorbent articles
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
DE60103299T2 (de) 2000-10-30 2005-05-12 Lupin Ltd., Mumbai Schnell zerfallende cefuroxim axetil enthaltende arzneizusammensetzung mit verzögerter wirkstoffabgabe
CA2514879C (en) 2003-01-03 2014-09-16 Shire Laboratories Inc. Two or more enteric materials to regulate drug release
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
EP1837020A1 (en) * 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
ES2360423T3 (es) 2006-04-26 2011-06-03 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal.
EP2090298A4 (en) * 2006-11-13 2014-02-26 Kyorin Seiyaku Kk METHOD FOR PRODUCING A TABLET WITH DELAYED RELEASE
CN102438617A (zh) 2009-03-27 2012-05-02 杏林制药株式会社 含有碱性添加剂的基质型缓释制剂
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
JP6456377B2 (ja) * 2014-06-10 2019-01-23 ライオン株式会社 清酒酵母を含有する錠剤
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ195933A (en) * 1980-01-11 1982-11-23 Boots Co Ltd Sustained-release pharmaceutical compositions in tablet form
JPS6024765B2 (ja) * 1981-11-27 1985-06-14 辰巳化学株式会社 セフアレキシンの持続性製剤の製造方法
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法

Also Published As

Publication number Publication date
MX10558A (es) 1993-11-01
PT86831B (pt) 1992-05-29
ZA881301B (en) 1989-10-25
IE880545L (en) 1988-08-27
EP0280571B1 (en) 1993-08-04
DE280571T1 (de) 1993-08-12
LV10184A (lv) 1994-10-20
AU604849B2 (en) 1991-01-03
PH24358A (en) 1990-06-13
CN88101062A (zh) 1988-09-07
LV10184B (en) 1995-04-20
IL85538A0 (en) 1988-08-31
ES2044825T1 (es) 1994-01-16
RU1831337C (ru) 1993-07-30
IE61419B1 (en) 1994-11-02
UA18251A (uk) 1997-12-25
CA1316110C (en) 1993-04-13
KR880009639A (ko) 1988-10-04
DK98088D0 (da) 1988-02-25
DE3882739T2 (de) 1994-02-17
KR960005140B1 (ko) 1996-04-22
JPS63227519A (ja) 1988-09-21
EG18523A (en) 1993-04-30
ES2044825T3 (es) 1994-11-16
GR930300027T1 (da) 1993-05-24
AU1219388A (en) 1988-09-01
AR243376A1 (es) 1993-08-31
JPH082793B2 (ja) 1996-01-17
IL85538A (en) 1991-09-16
CN1023765C (zh) 1994-02-16
ATE92309T1 (de) 1993-08-15
DE3882739D1 (de) 1993-09-16
NZ223619A (en) 1990-10-26
EP0280571A3 (en) 1989-01-04
HU202747B (en) 1991-04-29
EP0280571A2 (en) 1988-08-31
DK175620B1 (da) 2004-12-27
HK125793A (en) 1993-11-19
PT86831A (pt) 1988-03-01
HUT46531A (en) 1988-11-28
CY1741A (en) 1995-02-17

Similar Documents

Publication Publication Date Title
DK98088D0 (da) Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel
DK178285A (da) Catecholamin-holdig intranasal laegemiddelformulering med forsinket frigivelse af den aktive bestanddel
DK392281A (da) Pestcide midler med langsom frigorelse af den aktive bestanddel
DK708088A (da) Farmaceutisk praeparat med forlaenget frigivelsestid
FI890238A7 (fi) Aktiivista ainetta ohjelmoidusti vapauttavia galeenisia koostumuksia
DE69434479D1 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
DK263288A (da) Farmaceutisk praeparat af cefuroxim-axetil
DK583789D0 (da) System til transmucosal indgivelse af den aktive bestanddel af et laegemiddel
DE59003337D1 (de) Pressling mit retardierter Wirkstofffreisetzung.
FI930657A7 (fi) Menetelmä pidennetyn aktiiviaineluovutuksen omaavien annosmuotojen valmistamiseksi
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
FI925778A0 (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
DK386986A (da) Injicerbar halvfast farmaceutisk formulering med langsom frigivelse af den aktive bestanddel
KR920701213A (ko) 메틸렌디포스폰산 화합물 및 그것을 유효성분으로 하는 항염증제
NO910874L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
DK396286D0 (da) Injicerbar formulering med forsinket frigivelse af den aktive bestanddel
NO900697D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater.
DE69518193D1 (de) Präparat mit verzörgerter Wirkstoffabgabe
NO870104D0 (no) Farmasoeytisk preparat med vedvarende frigivelse av den aktive komponenten og fremgangsmaate for fremstilling derav.
DK226488A (da) Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
DK73980A (da) Insecticidt eller nematodicidt granulat med forhalet frigoerelse af den aktive bestanddel
FI891069A7 (fi) Suun kautta annettava järjestelmä vaikuttavan aineen säädettyä vapautumista varten
DK635988A (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
FI880210L (fi) Menetelmä valmistaa peroraalista stabiloitua, tehoainetta hidastetusti ja kontrolloidusti vapauttavaa, lääkevalmistetta

Legal Events

Date Code Title Description
PUP Patent expired